These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20364367)

  • 21. Body weight correlates with mortality in early-stage breast cancer.
    Enger SM; Greif JM; Polikoff J; Press M
    Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current clinical use of biomarkers for epithelial ovarian cancer.
    Moore RG; Maclaughlan S
    Curr Opin Oncol; 2010 Sep; 22(5):492-7. PubMed ID: 20613519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relation between health insurance coverage and clinical outcomes among women with breast cancer.
    Ayanian JZ; Kohler BA; Abe T; Epstein AM
    N Engl J Med; 1993 Jul; 329(5):326-31. PubMed ID: 8321261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
    Bristow RE; Palis BE; Chi DS; Cliby WA
    Gynecol Oncol; 2010 Sep; 118(3):262-7. PubMed ID: 20573392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of ovarian cancer in women residing in Aotearoa, New Zealand: 1993-2004.
    Firestone RT; Wong KC; Ellison-Loschmann L; Pearce N; Jeffreys M
    J Epidemiol Community Health; 2009 Oct; 63(10):814-9. PubMed ID: 19574244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S; Chapman W; McLaughlin J; Andrulis IL
    Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer.
    Wethington SL; Herzog TJ; Seshan VE; Bansal N; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Cancer; 2008 Dec; 113(12):3298-306. PubMed ID: 19006196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relation of reproductive factors to mortality from breast cancer.
    Daling JR; Malone KE; Doody DR; Anderson BO; Porter PL
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):235-41. PubMed ID: 11895871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.
    Duska LR; Garrett L; Henretta M; Ferriss JS; Lee L; Horowitz N
    Gynecol Oncol; 2010 Mar; 116(3):374-7. PubMed ID: 19922988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Early detection of ovarian cancer in FB&H--role of family medicine].
    Omeragić F; Ljuca D
    Med Arh; 2007; 61(2):77-81. PubMed ID: 17629138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer.
    Kim PS; Djazayeri S; Zeineldin R
    Gynecol Oncol; 2011 Mar; 120(3):393-403. PubMed ID: 21168905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: Predictive value of symptoms for early detection of ovarian cancer.
    Valdes R; Del Priore G
    J Natl Cancer Inst; 2010 Oct; 102(20):1599; author reply 1601. PubMed ID: 20829526
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Predictive value of symptoms for early detection of ovarian cancer.
    Jordan SJ; Coory MD; Webb PM;
    J Natl Cancer Inst; 2010 Oct; 102(20):1599-601; author reply 1601. PubMed ID: 20829525
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.
    Havrilesky LJ; Sanders GD; Kulasingam S; Chino JP; Berchuck A; Marks JR; Myers ER
    Cancer; 2011 Feb; 117(3):545-53. PubMed ID: 21254049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake.
    Byrne M; Sia TY; Fong C; Khurram A; Waters M; Kemel YM; Zhou Q; Ranganathan M; Long Roche K; Chi DS; Saban S; Wu M; Varice N; Hamilton JG; Carrot-Zhang J; Abu-Rustum NR; Iasonos A; Ellenson LH; Mandelker D; Weigelt B; Brown CL; Aghajanian C; Stadler Z; Liu YL
    Gynecol Oncol; 2024 Apr; 183():126-132. PubMed ID: 38493020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.